AGIO vs. ARQT
Compare and contrast key facts about Agios Pharmaceuticals, Inc. (AGIO) and Arcutis Biotherapeutics, Inc. (ARQT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AGIO or ARQT.
Correlation
The correlation between AGIO and ARQT is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AGIO vs. ARQT - Performance Comparison
Key characteristics
AGIO:
0.80
ARQT:
1.25
AGIO:
1.55
ARQT:
2.10
AGIO:
1.20
ARQT:
1.24
AGIO:
0.58
ARQT:
1.15
AGIO:
2.56
ARQT:
4.52
AGIO:
18.82%
ARQT:
21.51%
AGIO:
60.63%
ARQT:
77.19%
AGIO:
-87.36%
ARQT:
-95.02%
AGIO:
-74.81%
ARQT:
-64.58%
Fundamentals
AGIO:
$1.94B
ARQT:
$1.53B
AGIO:
$11.80
ARQT:
-$1.67
AGIO:
$25.77M
ARQT:
$125.18M
AGIO:
$19.92M
ARQT:
$112.96M
AGIO:
-$297.76M
ARQT:
-$109.21M
Returns By Period
In the year-to-date period, AGIO achieves a 3.50% return, which is significantly higher than ARQT's -5.96% return.
AGIO
3.50%
5.65%
-20.18%
43.32%
-6.83%
-10.90%
ARQT
-5.96%
-10.40%
45.56%
117.61%
-11.99%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AGIO vs. ARQT — Risk-Adjusted Performance Rank
AGIO
ARQT
AGIO vs. ARQT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Agios Pharmaceuticals, Inc. (AGIO) and Arcutis Biotherapeutics, Inc. (ARQT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AGIO vs. ARQT - Dividend Comparison
Neither AGIO nor ARQT has paid dividends to shareholders.
Drawdowns
AGIO vs. ARQT - Drawdown Comparison
The maximum AGIO drawdown since its inception was -87.36%, smaller than the maximum ARQT drawdown of -95.02%. Use the drawdown chart below to compare losses from any high point for AGIO and ARQT. For additional features, visit the drawdowns tool.
Volatility
AGIO vs. ARQT - Volatility Comparison
The current volatility for Agios Pharmaceuticals, Inc. (AGIO) is 12.25%, while Arcutis Biotherapeutics, Inc. (ARQT) has a volatility of 18.93%. This indicates that AGIO experiences smaller price fluctuations and is considered to be less risky than ARQT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AGIO vs. ARQT - Financials Comparison
This section allows you to compare key financial metrics between Agios Pharmaceuticals, Inc. and Arcutis Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities